B. Bode-lesniewska et al., Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery, VIRCHOWS AR, 438(1), 2001, pp. 57-65
Citations number
28
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
The characterization of clinical, histopathological, immunohistochcmical, a
nd genetic features of intimal sarcomas arising in the pulmonary artery is
presented in this study. Four resected lungs, one endarterectomy specimen a
nd three biopsies from eight patients (four males and four females; median
age 41 years) suffering from intimal sarcomas of the pulmonary artery using
conventional stains, immunohistochemistry, and comparative genomic hybridi
zation (CGH) were analyzed. The predominant clinical presentation was dyspn
ea (all eight patients) and febrile pulmonary disease (six of eight). Signs
of embolic lung disease were present in all patients. One patient died pos
toperatively, six patients died of disease 8-35 months after presentation,
and one patient was alive 6 months after surgery. Histopathological examina
tion of the submitted material showed spindle cell, partially myxoid and pl
eomorphic sarcomas. Metastases were histologically confirmed in three patie
nts (lung, pleura, and skull). Immunohistochemically, vimentin was strongly
expressed in all tumors. Focal positivity was observed fur alpha smooth mu
scle actin, CD117, CD68, p53, and bc12. No reaction could be obtained for e
ndothelial markers. The proliferation index Ki-67 was between 5% and 80%. S
ix examined tumors were positive for mdm2. In the CGH analysis, gains and a
mplifications in the 12q13-14 region were found in six of eight tumors (75%
). Other, less consistent alterations, were losses on 3p, 3q, 4q, 9p, 11q,
13q, Xp, and Xq, gains on 7p, 17p, and 17q, and amplifications on 4q, 5D, 6
p, and 11q. Intimal sarcomas of the pulmonary artery are tumors with an unf
avorable prognosis and poorly differentiated morphology. A majority of tumo
rs show a consistent genetic alteration (gains and amplifications in the 12
q13-14 region) and overexpression of mdm2, implicating the mdm2/p53 pathway
as a possible mechanism in the tumor pathogenesis.